Breast cancer cells with a CD44+/CD24low/- surface phenotype were found to have tumor-initiating properties with stem-cell like features and invasive ability [3], however it is unclear whether their presence in a tumor has clinical implications [4]. Here, CD44 is linked to breast carcinoma.